Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recalcitrant Wet Age-related Macular Degeneration”

2 trials

Showing 2 of 2 results

Testing effectiveness (Phase 2)Study completedNCT01972763
What this trial is testing

Ranibizumab for Recalcitrant Wet Age-related Macular Degeneration in Eyes Previously Switched From Bevacizumab and/or Ranibizumab to Aflibercept.

Who this might be right for
Recalcitrant Wet Age-related Macular Degeneration
Northern California Retina Vitreous Associates 12
Testing effectiveness (Phase 2)Looking for participantsNCT04504123
What this trial is testing

MMP-9 Inhibition for Recalcitrant Wet AMD

Who this might be right for
Exudative Macular DegenerationWet Age-related Macular Degeneration
University of Iowa 50

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation